>
Switch to:

Teladoc Health Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 2015. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Teladoc Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Teladoc Health's Piotroski F-Score or its related term are showing as below:

NYSE:TDOC' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 4

2
5

During the past 8 years, the highest Piotroski F-Score of Teladoc Health was 5. The lowest was 2. And the median was 4.


Teladoc Health Piotroski F-Score Historical Data

The historical data trend for Teladoc Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 3.00 4.00 3.00

Teladoc Health Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 3.00 4.00 4.00

Competitive Comparison

For the Health Information Services subindustry, Teladoc Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Teladoc Health Piotroski F-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Teladoc Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun21) TTM:Last Year (Jun20) TTM:
Net Income was -35.884 + -393.967 + -199.649 + -133.819 = $-763 Mil.
Cash Flow from Operations was 32.195 + -114.936 + -18.026 + 52.217 = $-49 Mil.
Revenue was 288.812 + 383.321 + 453.675 + 503.139 = $1,629 Mil.
Gross Profit was 184.087 + 260.379 + 307.716 + 342.866 = $1,095 Mil.
Average Total Assets from the begining of this year (Jun20)
to the end of this year (Jun21) was
(2418.828 + 3449.385 + 17755.281 + 17582.358 + 17611.119) / 5 = $11763.3942 Mil.
Total Assets at the begining of this year (Jun20) was $2,419 Mil.
Long-Term Debt & Capital Lease Obligation was $1,238 Mil.
Total Current Assets was $1,105 Mil.
Total Current Liabilities was $276 Mil.
Net Income was -20.346 + -19.044 + -29.603 + -25.682 = $-95 Mil.

Revenue was 137.969 + 156.489 + 180.799 + 241.03 = $716 Mil.
Gross Profit was 95.17 + 101.134 + 108.417 + 150.25 = $455 Mil.
Average Total Assets from the begining of last year (Jun19)
to the end of last year (Jun20) was
(1565.344 + 1568.429 + 1602.827 + 1603.077 + 2418.828) / 5 = $1751.701 Mil.
Total Assets at the begining of last year (Jun19) was $1,565 Mil.
Long-Term Debt & Capital Lease Obligation was $976 Mil.
Total Current Assets was $1,403 Mil.
Total Current Liabilities was $124 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teladoc Health's current Net Income (TTM) was -763. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teladoc Health's current Cash Flow from Operations (TTM) was -49. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun20)
=-763.319/2418.828
=-0.31557391

ROA (Last Year)=Net Income/Total Assets (Jun19)
=-94.675/1565.344
=-0.06048191

Teladoc Health's return on assets of this year was -0.31557391. Teladoc Health's return on assets of last year was -0.06048191. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Teladoc Health's current Net Income (TTM) was -763. Teladoc Health's current Cash Flow from Operations (TTM) was -49. ==> -49 > -763 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun20 to Jun21
=1237.532/11763.3942
=0.10520195

Gearing (Last Year: Jun20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun19 to Jun20
=976.118/1751.701
=0.55724008

Teladoc Health's gearing of this year was 0.10520195. Teladoc Health's gearing of last year was 0.55724008. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun21)=Total Current Assets/Total Current Liabilities
=1104.837/276.227
=3.99974297

Current Ratio (Last Year: Jun20)=Total Current Assets/Total Current Liabilities
=1403.11/123.548
=11.3568006

Teladoc Health's current ratio of this year was 3.99974297. Teladoc Health's current ratio of last year was 11.3568006. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Teladoc Health's number of shares in issue this year was 156.055. Teladoc Health's number of shares in issue last year was 76.513. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1095.048/1628.947
=0.67224287

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=454.971/716.287
=0.63517975

Teladoc Health's gross margin of this year was 0.67224287. Teladoc Health's gross margin of last year was 0.63517975. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun20)
=1628.947/2418.828
=0.67344474

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun19)
=716.287/1565.344
=0.45759079

Teladoc Health's asset turnover of this year was 0.67344474. Teladoc Health's asset turnover of last year was 0.45759079. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Teladoc Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Teladoc Health  (NYSE:TDOC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Teladoc Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Teladoc Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Teladoc Health Business Description

Teladoc Health logo
Industry
Traded in Other Exchanges
Address
2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Executives
Gorevic Jason N director, officer: Chief Executive Officer PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: GOREVIC JASON N a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Vandervoort Adam C officer: Chief Legal Officer, Secretary 485 MADISON AVENUE NEW YORK NY 10022
Turitz Andrew officer: SVP - Business Development C/O TELADOC, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Levy Lewis officer: Chief Medical Officer C/O TELADOC, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Verstraete Stephany officer: Chief Marketing Officer C/O TELADOC, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Frist William H. director 600 MONTGOMERY STREET SAN FRANCISCO CA 94111
Bucaria Michelle officer: Chief Human Resources Officer C/O TELADOC, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Sides David William officer: Chief Operating Officer 1230 PEACHTREE STREET NE SUITE 600 ATLANTA GA 30309
Caridi Christopher officer: Chief Accounting Officer C/O 111 RIVER STREET HOBOKEN NJ 07030
Murthy Mala officer: Chief Financial Officer C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Shedlarz David L director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SHEDLARZ DAVID L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Goldstein Michael director 3 EAST 84 STREET NEW YORK NY 10028
Darling Helen director 2 MANHATTANVILLE ROAD SUITE 203 PURCHASE NY 10577
Paulus Kenneth H director 5420 FELTL ROAD MINNETONKA MN 55343
Mckinley Thomas director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: MCKINLEY THOMAS a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}

Teladoc Health Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)